Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.5%

211 terminated/withdrawn out of 1277 trials

Success Rate

77.0%

-9.6% vs industry average

Late-Stage Pipeline

8%

96 trials in Phase 3/4

Results Transparency

43%

305 of 706 completed trials have results

Key Signals

181 recruiting305 with results146 terminated65 withdrawn

Enrollment Performance

Analytics

N/A
531(54.1%)
Phase 2
169(17.2%)
Phase 1
130(13.2%)
Early Phase 1
56(5.7%)
Phase 4
51(5.2%)
Phase 3
45(4.6%)
982Total
N/A(531)
Phase 2(169)
Phase 1(130)
Early Phase 1(56)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1277)

Showing 20 of 1277 trials
NCT01659203Phase 1Recruiting

Proton or Photon RT for Retroperitoneal Sarcomas

Role: collaborator

NCT06857903Not ApplicableCompleted

Using Nudges to Recruit for Health-Related Research

Role: lead

NCT05514002Phase 4Completed

Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years

Role: collaborator

NCT04376489Not ApplicableCompleted

Project MARS: Mobile-Assistance for Regulating Smoking

Role: lead

NCT04763902Not ApplicableCompleted

Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer

Role: lead

NCT05918029Phase 2Terminated

Bone in CKD Alkali Response (BICARb Pilot Trial)

Role: collaborator

NCT01339052Phase 2Completed

Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma

Role: collaborator

NCT05634252Phase 3Active Not Recruiting

Undergraduate Skin Cancer Prevention Trial

Role: lead

NCT05607381Not ApplicableRecruiting

Neural Mechanisms of Meditation for Opioid-Treated Chronic Low Back Pain

Role: lead

NCT04112186Not ApplicableCompleted

Mindfulness-Oriented Recovery Enhancement (MORE) in Heroin Addiction

Role: collaborator

NCT03796767Phase 2Completed

Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer

Role: lead

NCT04163432Phase 2Terminated

Staggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed & Carboplatin (PC) for Metastatic Non-Squamous NSCLC

Role: lead

NCT07716280Not ApplicableRecruiting

Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics

Role: lead

NCT04409639Phase 2Active Not Recruiting

Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway Mutations

Role: lead

NCT04199000Recruiting

Clinical and Basic Investigations Into Congenital Disorders of Glycosylation

Role: collaborator

NCT07698522Not ApplicableRecruiting

Digital Technology-Informed Stroke Rehabilitation

Role: lead

NCT07713095Not ApplicableNot Yet Recruiting

Waning Moon: A Whole Person Health Intervention Designed by and for Urban Menopausal American Indian/Alaska Native Women

Role: lead

NCT07173101Phase 2Suspended

Clinical Investigation of the Effects of Semiconductor Embedded Therapeutic Garments on Cancer-related Cognitive Impairment in Breast and Gynecological Cancer Patients

Role: lead

NCT07712133Not ApplicableNot Yet Recruiting

Improving Radon Education and Awareness in Cancer Patients and Their Extended Community

Role: lead

NCT05706311Not ApplicableActive Not Recruiting

Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool

Role: lead